Publications
Bioequivalence study of generic nirmatrelvir in healthy volunteersOseshnyuk R.A., Nikiforova A.G., Boroduleva A.Yu., Sobolev P.A., Lesnichuk S.A., Garyaev B.B., Abramova A.A., Mozgovaya V.G., Filon O.V., Zinkovskaya A.V., Dolgorukova A.N., Khanonina E.K., Ignatiev V.G., Samsonov M.Yu.Download documentDissolution Profile Study and Uniformity of Dosage Units Test for Various Manufacturers of "Captopril" Drugs from the Russian MarketGrebenkin D.Yu., Ryabova A.V., Kuramshina A.M., Kislyakov I.V., Zhukova E.D.Download documentPharmacokinetic and Bioequivalence Study of the Two-component Drug Product "Ezetimibe + rosuvastatin" (JSC "Sanofi-aventis group", Russia): Resuts and Experience with the Use of Enzymatic Hydrolysis in the Analysis of SamplesAlexander L. Khokhlov, Dmitrii Yu. Grebenkin, Ekaterina K. Faeva, Vasily I. Kazey,
Alexander A. Khokhlov, Alexey E. Miroshnikov, Olga V. LebedevaDownload documentInterferon status of a person.
Problems of standardization of the study, and the establishment of reference valuesA.V. Lobov, E.A. Pogodina, P.I. Ivanova, N.V. Ugarova, E.V. Sorokina, I.Zh. ShubinDownload documentAssessing How Residual Errors of Scoring Functions Correlate to Ligand Structural FeaturesDmitry A. Shulga * ,
Arslan R. Shaimardanov ,
Nikita N. Ivanov and Vladimir A. PalyulinDownload documentAntitumor immunotherapy and COVID-19 in cancer patientsEkaterina A. Pogodina, Irina Zh. Shubina, Anton V. Lobov, Polina I. Ivanova, Nikolay Yu. SokolovDownload documentBioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixeddose combination Lozap® AM and monocomponent drug Crestor® in healthy subjectsKhokhlov A.L., Grebenkin D.Yu., Faeva E.K., Kazey V.I., Khokhlov A.A., Miroshnikov A.E., Lebedeva O.V.Download documentResults of a clinical study of safety, pharmacokinetics, and pharmacodynamics of an original antiplatelet drug from the group of glycoprotein IIb/IIIa-receptor inhibitors in healthy volunteersFitilyov S.B., Glukhov Y.F., Lukyanov S.V., Vozzhaev A.V., Shkrebneva I.I., Kazey V.I., Bondareva I.B.Download documentIn Silico Structure-Based Approach for Group Efficiency Estimation in Fragment-Based Drug Design Using Evaluation of Fragment ContributionsDmitry A. Shulga, Nikita N. Ivanov and Vladimir A. PalyulinDownload documentInduction of anti-SARS-CoV-2 immune reactions in immune compromised patientsPogodina E.A., Lobov A.V.,
Ivanova P.I., Kazey V.I.,
Shubina I.Z.Download documentAssessment of the cellular immunity response to the new coronavirus infection COVID-19Lobov A.V., Ivanova P.I.,
Pogodina E.A., Kazey V.I.,
Maksimova E.D., Shubina I.Z.Download documentPharmacokinetic and bioequivalence study of the two-component drug Telzap AM® (telmisartan / amlodipine) and co-administered monocomponent preparations Mikardis® (telmisartan) and Norvasc® (amlodipine) in healthy volunteersV. Kubesh, A. L. Khokhlov,
A. M. Shitova, Yu. A. Dzhurko,
V. I. Kazei, A. A. Khokhlov,
A. E. Miroshnikov, O. V. Lebedeva,
I. K. Klaus, A. V. ZyatenkovDownload documentEffect of dose level of the selective FGFR2 inhibitor alofanib on toxicity, pharmacokinetics and preliminary efficacy: A phase Ib study in patients with advanced gastric cancer (RPT835GC1B)I. Tsimafeyeu, V. Kazey, N. Dragun,
D. Reznikov, E. Gavrilova, S. Gorbacheva, A. Nikiforova, M. Byakhov, S. TjulandinDownload documentFIRST-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynam ics in prostate cancer patientsN. V. Eremina, V. I. Kazey,
S. V. Mishugin, R. V. Leonenkov,
D. Y. Pushkar, V. L. Mett
and A. V. GudkovDownload documentA Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS StudyNikita V. Lomakin,
Lyudmila I. Buryachkovskaya,
Denis A. Zolin, Vasily I. KazeyDownload documentDevelopment and Validation of Approach for the Detection of Neutralizing Antibodies Against Insulin (Glargine) in Human Blood Plasma Natalia B. Abramenko,
Polina I. Vnukova, Elena S. Golovina,
Igor Е. Makarenko, Anna A. Mosikian,
Aiyyna G. Nikiforova, Polina V. Gremyakova, Vasily I. Kazey Download documentRandomised crossover comparative study of safety, tolerance and pharmacokinetics of Primapur vs. Gonal-F upon single-dose subcutaneous administration in healthy volunteersE. E. Tyul’kina, I. G. Gordeev,
D. Yu. Grebenkin, V. A. Kazey,
M. M. Tsikarishvili , E. E. Luchinkina,
B. H. Abdulla, S. Samandari,
I. I. Vorob’ev, A. F. Shigabutdinov,
and M. A. PolzikovDownload documentApplication of the method of liquid chromate-mass spectrometry for determination of bisoprolol and atorvastatin N. Duhovskaya, T. Vavilova,
S. Gorbacheva, P. Gremyakova,
I. OstrovskayaDownload documentDissolution profile study of extended release valproic acid drug products from different manufacturers D.Yu. Grebenkin, E.D. Ustinova,
S.Yu. Gorbacheva, A.K. Faeva,
V.I. Kazey, A.V. RyabovDownload document
A. M. Shitova, Yu. A. Dzhurko,
V. I. Kazei, A. A. Khokhlov,
A. E. Miroshnikov, O. V. Lebedeva,
I. K. Klaus, A. V. ZyatenkovDownload documentEffect of dose level of the selective FGFR2 inhibitor alofanib on toxicity, pharmacokinetics and preliminary efficacy: A phase Ib study in patients with advanced gastric cancer (RPT835GC1B)I. Tsimafeyeu, V. Kazey, N. Dragun,
D. Reznikov, E. Gavrilova, S. Gorbacheva, A. Nikiforova, M. Byakhov, S. TjulandinDownload documentFIRST-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynam ics in prostate cancer patientsN. V. Eremina, V. I. Kazey,
S. V. Mishugin, R. V. Leonenkov,
D. Y. Pushkar, V. L. Mett
and A. V. GudkovDownload documentA Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS StudyNikita V. Lomakin,
Lyudmila I. Buryachkovskaya,
Denis A. Zolin, Vasily I. KazeyDownload documentDevelopment and Validation of Approach for the Detection of Neutralizing Antibodies Against Insulin (Glargine) in Human Blood Plasma Natalia B. Abramenko,
Polina I. Vnukova, Elena S. Golovina,
Igor Е. Makarenko, Anna A. Mosikian,
Aiyyna G. Nikiforova, Polina V. Gremyakova, Vasily I. Kazey Download documentRandomised crossover comparative study of safety, tolerance and pharmacokinetics of Primapur vs. Gonal-F upon single-dose subcutaneous administration in healthy volunteersE. E. Tyul’kina, I. G. Gordeev,
D. Yu. Grebenkin, V. A. Kazey,
M. M. Tsikarishvili , E. E. Luchinkina,
B. H. Abdulla, S. Samandari,
I. I. Vorob’ev, A. F. Shigabutdinov,
and M. A. PolzikovDownload documentApplication of the method of liquid chromate-mass spectrometry for determination of bisoprolol and atorvastatin N. Duhovskaya, T. Vavilova,
S. Gorbacheva, P. Gremyakova,
I. OstrovskayaDownload documentDissolution profile study of extended release valproic acid drug products from different manufacturers D.Yu. Grebenkin, E.D. Ustinova,
S.Yu. Gorbacheva, A.K. Faeva,
V.I. Kazey, A.V. RyabovDownload document